Survey reach. by Abigail A. Lee (19935335)

Hydroxyl Defects in LiFePO₄ Cathode Material: DFT+<i>U</i> and an Experimental Study by Dmitry A. Aksyonov (4918594)

“…The presence of D (H) at both Li and P sites for hydrothermally synthesized deuterium-enriched LiFePO₄ is confirmed by joint X-ray and neutron powder diffraction structure refinement at 5 K that also reveals a strong deficiency of P of 6%. The P occupancy decrease is explained by the formation of hydrogarnet-like P/4H and P/5H defects, which have the lowest formation energies among all considered OH defects. …”

Effect of compound 16 and m-AMSA on relaxation of supercoiled pBS-SK (+) DNA by human recombinant Topo II. by Ahmed A. Gaber (13302308)

Pre-analysis data cleaning. by Abigail A. Lee (19935335)

The contributions from the different energy components of MM-GBSA. by Ahmed A. Gaber (13302308)

Model projections for East/Southeast Asian TB epidemic assuming continuation of current practice. by Emily A. Kendall (497397)

Binding of compound 19 with DNA-Topo II complex. by Ahmed A. Gaber (13302308)

The immunoblotting of BAX and Bcl-2 (Normalized to β-actin). by Ahmed A. Gaber (13302308)

Fit statistics for CFA analysis of the latent variable “intent to vaccinate against HPV”. by Abigail A. Lee (19935335)

Binding of compound 12b with DNA-Topo II complex. by Ahmed A. Gaber (13302308)

The antiproliferative activities of the tested compounds toward HepG2, and HCT‐116 cell lines, Topo II activity, and DNA‐intercalating affinity. by Ahmed A. Gaber (13302308)

The docking binding free energies (ΔG) of the synthesized compounds with DNA-topoisomerase II complex. by Ahmed A. Gaber (13302308)

The rationale of molecular design of new DNA-intercalators. by Ahmed A. Gaber (13302308)

Sustained Intensive treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in persons with type 1 diabetes treated with MDI by Marcus Lind (267226)

“…Persons completing the trial (n=141) were invited to participate in the current SILVER extension study in which 107 patients continued CGM treatment over 1 year along with the support of a diabetes nurse every 3 months. <br> <br> </p> <p>Results: The primary endpoint, change in HbA1c over 1.0-1.5 years CGM use compared with previous self-monitoring of blood glucose (SMBG) during GOLD, showed a decrease in HbA1c of 0.35% (95% CI 0.19-0.50), p<0.001. …”

Orsay virus infection of the <i>lin-8(n2731</i>) synMuv A mutant induces a Muv phenotype indicative of decreased synMuv B gene activity, and 2 different synMuv B mutants produce 50–100× less Orsay virus RNA. by Ashwin Seetharaman (615458)

Description of the study outcomes by categories of SEN provision in Year 1^(a). by Vincent Nguyen (8044031)

KEGG enrichment map of differential metabolites (a) and differential abundance score map (b). by Jun Sun (48981)

Detected metabolites (a), volcano plot (b) and scatter plot (c) of differential metabolites. by Jun Sun (48981)

HbA1c, BMI and Lipid levels of study participants (n = 382). by Habiba I. Ali (10451382)

Subjects:

Successful Management of Postoperative Chylothorax in a Neonate after Coarctation Repair by Sameh M. Said (8697503)

“…<p>This is a 3.8 kg, 6-day old neonate whose initial presentation was a cardiogenic shock secondary to ductal closure. …”